Congress Passes FDA User Fee Reauthorization Bill

Congress has completed action reauthorizing FDA’s user fees. The bill now goes to the President.

img_7869The United States Senate has passed HR 2430 by a vote of 94 – 1, legislation to reauthorize user fees collected by the Food & Drug Administration (FDA). The bill, which previously passed the House, now goes to the President’s desk.

Without these user fees, the agency would be forced to RIF or furlough employees. While NTEU took no position on the particulars of the user fee legislation, we have repeatedly urged Congress to act in time to avoid expiration of these fees. We further informed Congress that the NTEU-represented employees at FDA have the right to sixty days’ notice before any RIF or furlough. Therefore, we asked that Congress act before the notices are required to be sent to employees in order to avoid the disruption these notices will cause.

President Donald J. Trump
President Donald J. Trump

The Administration has not supported the legislation passed by Congress but has not been significantly involved in shaping an alternative version. Should the President veto this bill it is possible that final action would not occur before the expiration of the fees.

NTEU will continue to be a voice for our members at FDA as this process moves forward and will keep you updated. If you have any immediate questions, please contact your chapter president.

Author: chapterpresident

I have worked in the FDA since 1990 in a variety of positions. I currently serve as chapter president of NTEU Chapter 254, representing FDA employees in Arkansas, Colorado, Iowa, Kansas, Missouri, Nebraska, New Mexico, Oklahoma, Texas, and Utah.